Christina S Yee1, Michel J Massaad1, Wayne Bainter1, Toshiro K Ohsumi2, Niko Föger3, Andrew C Chan4, Nurten A Akarsu5, Caner Aytekin6, Deniz Çagdas Ayvaz7, Ilhan Tezcan7, Özden Sanal7, Raif S Geha8, Janet Chou1. 1. Division of Immunology, Boston Children's Hospital and Department of Pediatrics, Harvard Medical School, Boston, Mass. 2. Department of Molecular Biology, Massachusetts General Hospital and Department of Genetics, Harvard Medical School, Boston, Mass. 3. Institute of Clinical Chemistry, Hannover Medical School, Hannover, Germany. 4. Genentech, San Francisco, Calif. 5. Department of Medical Genetics, Hacettepe University Medical Faculty, Ankara, Turkey. 6. Dr Sami Ulus Children's Health and Diseases Training and Research Center, Ankara, Turkey. 7. Hacettepe University and Ihsan Doğramacı Children's Hospital, Ankara, Turkey. 8. Division of Immunology, Boston Children's Hospital and Department of Pediatrics, Harvard Medical School, Boston, Mass. Electronic address: Raif.Geha@childrens.harvard.edu.
Abstract
BACKGROUND: Coronin-1A (CORO1A) is a regulator of actin dynamics important for T-cell homeostasis. CORO1A deficiency causes T(-)B(+) natural killer-positive severe combined immunodeficiency or T-cell lymphopenia with severe viral infections. However, because all known human mutations in CORO1A abrogate protein expression, the role of the protein's functional domains in host immunity is unknown. OBJECTIVE: We sought to identify the cause of the primary immunodeficiency in 2 young adult siblings with a history of disseminated varicella, cutaneous warts, and CD4(+) T-cell lymphopenia. METHODS: We performed immunologic, genetic, and biochemical studies in the patients, family members, and healthy control subjects. RESULTS: Both patients had CD4(+) T-cell lymphopenia and decreased lymphocyte proliferation to mitogens. IgG, IgM, IgA, and specific antibody responses were normal. Whole-genome sequencing identified a homozygous frameshift mutation in CORO1A disrupting the last 2 C-terminal domains by replacing 61 amino acids with a novel 91-amino-acid sequence. The CORO1A(S401fs) mutant was expressed in the patients' lymphocytes at a level comparable with that of wild-type CORO1A in normal lymphocytes but did not oligomerize and had impaired cytoskeletal association. CORO1A(S401fs) was associated with increased filamentous actin accumulation in T cells, severely defective thymic output, and impaired T-cell survival but normal calcium flux and cytotoxicity, demonstrating the importance of CORO1A oligomerization and subcellular localization in T-cell homeostasis. CONCLUSIONS: We describe a truncating mutation in CORO1A that permits protein expression and survival into young adulthood. Our studies demonstrate the importance of intact CORO1A C-terminal domains in thymic egress and T-cell survival, as well as in defense against viral pathogens.
BACKGROUND:Coronin-1A (CORO1A) is a regulator of actin dynamics important for T-cell homeostasis. CORO1Adeficiency causes T(-)B(+) natural killer-positive severe combined immunodeficiency or T-cell lymphopenia with severe viral infections. However, because all known human mutations in CORO1A abrogate protein expression, the role of the protein's functional domains in host immunity is unknown. OBJECTIVE: We sought to identify the cause of the primary immunodeficiency in 2 young adult siblings with a history of disseminated varicella, cutaneous warts, and CD4(+) T-cell lymphopenia. METHODS: We performed immunologic, genetic, and biochemical studies in the patients, family members, and healthy control subjects. RESULTS: Both patients had CD4(+) T-cell lymphopenia and decreased lymphocyte proliferation to mitogens. IgG, IgM, IgA, and specific antibody responses were normal. Whole-genome sequencing identified a homozygous frameshift mutation in CORO1A disrupting the last 2 C-terminal domains by replacing 61 amino acids with a novel 91-amino-acid sequence. The CORO1A(S401fs) mutant was expressed in the patients' lymphocytes at a level comparable with that of wild-type CORO1A in normal lymphocytes but did not oligomerize and had impaired cytoskeletal association. CORO1A(S401fs) was associated with increased filamentous actin accumulation in T cells, severely defective thymic output, and impaired T-cell survival but normal calcium flux and cytotoxicity, demonstrating the importance of CORO1A oligomerization and subcellular localization in T-cell homeostasis. CONCLUSIONS: We describe a truncating mutation in CORO1A that permits protein expression and survival into young adulthood. Our studies demonstrate the importance of intact CORO1A C-terminal domains in thymic egress and T-cell survival, as well as in defense against viral pathogens.
Authors: C L Shovlin; H A Simmonds; L D Fairbanks; S J Deacock; J M Hughes; R I Lechler; A D Webster; X M Sun; J C Webb; A K Soutar Journal: J Immunol Date: 1994-09-01 Impact factor: 5.422
Authors: Roshini S Abraham; Mike Recher; Silvia Giliani; Jolan E Walter; Yu Nee Lee; Francesco Frugoni; Daniel E Maddox; Salman Kirmani; Luigi D Notarangelo Journal: J Allergy Clin Immunol Date: 2012-11-02 Impact factor: 10.793
Authors: Asbjorg Stray-Pedersen; Emmanuelle Jouanguy; Amandine Crequer; Alison A Bertuch; Betty S Brown; Shalini N Jhangiani; Donna M Muzny; Tomasz Gambin; Hanne Sorte; Ghadir Sasa; Denise Metry; Judith Campbell; Marianna M Sockrider; Megan K Dishop; David M Scollard; Richard A Gibbs; Emily M Mace; Jordan S Orange; James R Lupski; Jean-Laurent Casanova; Lenora M Noroski Journal: J Clin Immunol Date: 2014-07-30 Impact factor: 8.317
Authors: Kerry Dobbs; Cecilia Domínguez Conde; Shen-Ying Zhang; Silvia Parolini; Magali Audry; Janet Chou; Emma Haapaniemi; Sevgi Keles; Ivan Bilic; Satoshi Okada; Michel J Massaad; Samuli Rounioja; Adel M Alwahadneh; Nina K Serwas; Kelly Capuder; Ergin Çiftçi; Kerstin Felgentreff; Toshiro K Ohsumi; Vincent Pedergnana; Bertrand Boisson; Şule Haskoloğlu; Arzu Ensari; Michael Schuster; Alessandro Moretta; Yuval Itan; Ornella Patrizi; Flore Rozenberg; Pierre Lebon; Janna Saarela; Mikael Knip; Slavé Petrovski; David B Goldstein; Roberta E Parrott; Berna Savas; Axel Schambach; Giovanna Tabellini; Christoph Bock; Talal A Chatila; Anne Marie Comeau; Raif S Geha; Laurent Abel; Rebecca H Buckley; Aydan İkincioğulları; Waleed Al-Herz; Merja Helminen; Figen Doğu; Jean-Laurent Casanova; Kaan Boztuğ; Luigi D Notarangelo Journal: N Engl J Med Date: 2015-06-18 Impact factor: 91.245
Authors: A Grogan; E Reeves; N Keep; F Wientjes; N F Totty; A L Burlingame; J J Hsuan; A W Segal Journal: J Cell Sci Date: 1997-12 Impact factor: 5.285
Authors: Sol A Ban; Elisabeth Salzer; Martha M Eibl; Angela Linder; Christoph B Geier; Elisangela Santos-Valente; Wojciech Garncarz; Thomas Lion; Raphael Ott; Christoph Seelbach; Kaan Boztug; Hermann M Wolf Journal: J Clin Immunol Date: 2014-09-10 Impact factor: 8.317
Authors: Qian Zhang; Christopher G Dove; Jyh Liang Hor; Heardley M Murdock; Dara M Strauss-Albee; Jordan A Garcia; Judith N Mandl; Rachael A Grodick; Huie Jing; Devon B Chandler-Brown; Timothy E Lenardo; Greg Crawford; Helen F Matthews; Alexandra F Freeman; Richard J Cornall; Ronald N Germain; Scott N Mueller; Helen C Su Journal: J Exp Med Date: 2014-11-24 Impact factor: 14.307